
Research examines effects of HMB supplementation for muscle support in older adults
Two recently published studies analyzed β-hydroxy β-methylbutyrate (HMB) supplementation dosages and its role in muscle loss prevention.
In a recent press release, TSI Group commented on two recently published studies on the effects of the nutrient β-hydroxy β-methylbutyrate (HMB) on muscle loss in older adults. The studies offered research on dosing and duration as well as its potential use in sarcopenia.
“The global population is aging rapidly, and consumers are increasingly looking for proactive solutions to stay strong, mobile and independent. Brands must meet this shift head-on. Ingredients such as HMB, with clinically confirmed benefits, offer an incredible opportunity to deliver meaningful support to the 50+ demographic,” stated TSI Group vice president of business development Shawn Baier, MS, MBA, in the press release.
The first
“This new meta-analysis validates what we at TSI have been championing for years: HMB is a scientifically proven ingredient that supports muscle health and function as we age,” stated Baier. “We’ve long understood the critical role HMB plays in addressing age-related muscle loss, and it’s rewarding to see the clinical community continue to affirm that.”
The second
References
- Li, N.; Chen, S.; He, Y.; Chen, Y.; Duan, X.; He, W.; Wang, Q.; Liu, S.; Liu, T.; Fang, H. Effects of oral supplementation of β -hydroxy-β -methylbutyrate on muscle mass and strength in individuals over the age of 50: a meta-analysis. Front. Nutr. 2025. DOI:
10.3389/fnut.2025.1522287 - Barone, M.; Baccaro, P.; Molfino, A. An Overview of Sarcopenia: Focusing on Nutritional Treatment Approaches. Nutrients. 2025. DOI:
10.3390/nu17071237
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





